Most recently, we have described the G-protein coupled receptor 83 (GPR83), which is highly expressed by CD4 þ CD25 þ regulatory T cells (Tregs) to be involved in the induction of CD4 þ Foxp3 þ Tregs in the course of an ongoing immune response. Four GPR83 isoforms have been described. Here, we have shown that GPR83 isoform-4, which differs from GPR83 isoform-1 by 20 additional aminoacids in the second cytoplasmatic loop, is predominantly expressed by Tregs. Interestingly, GPR83 isoform-4 but not GPR83 isoform-1 retrovirally transduced T cells were able to interfere with inflammatory responses in vivo. Re-analysis of GPR83 transduced T cells revealed that this in vivo acquisition of suppressive activity was associated with the induction of Treg-associated molecules including Foxp3 in GPR83 isoform-4 but not GPR83 isoform-1 transduced CD4 þ T cells under inflammatory conditions. Our results suggest that the 20 additional aminoacids within GPR83 isoform-4 are involved in Treg induction during inflammatory immune responses.
Introduction
Besides naturally occurring thymus-derived CD4 þ
CD25
þ Foxp3 þ Tregs a broad variety of peripherally induced Tregs have been described. 1 This heterogeneous subset of Tregs can be induced by antigen presentation under subimmunogenic conditions or in the presence of immunosuppressive cytokines such as IL-10 or TGF-b. [2] [3] [4] However, the exact mechanism and molecules involved in the induction of Tregs remain poorly understood. Most recently, we have identified G-protein coupled receptor 83 (GPR83) to be involved in the peripheral induction of CD4 þ Foxp3 þ Tregs in the course of active immune responses. 5 GPR83 is an orphan seven-transmembrane-domain GPR homologous to the tachykinin and neuropeptide Y receptors, 6 which was originally identified among genes induced by glucocorticoids and cAMP in the T-cell line WEHI-7TG. 7 Four different GPR83 isoforms have been described until now.
Several groups, including ours, described GPR83 to be differentially expressed by CD4 þ Foxp3 þ Tregs 5, [8] [9] [10] in contrast to recently activated or naive T cells. However, overexpression of GPR83 in naive CD4 þ T cells by retroviral gene transfer did not confer a regulatory phenotype by means of Foxp3 expression, impaired proliferation on stimulation and inhibitory activity in vitro. 5, 9 Interestingly, GPR83 transduced T cells acquire Foxp3 expression and exhibit immunosuppressive function under inflammatory conditions in vivo 5 suggesting that a putative GPR83 ligand is present during ongoing immune responses with the ability to induce Foxp3 expression in GPR83 þ T cells.
Results and discussion
GPR83 isoform-4 is highly expressed by CD4 þ CD25 þ regulatory T cells For a better understanding of Treg biology, several groups, including ours, have performed extensive gene expression profiles of Tregs using microarray technology. One molecule that has emerged from these studies is GPR83. 5, 8, 9 However, four different isoforms of GPR83 have been described in mice, whereas we have no evidence for different GPR83 isoforms in the human system. Murine GPR83 isoform-1 encodes for 423 aminoacids (aa) whereas isoform-2 represents a shorter form of 381 aa. Isoform-3 as well as isoform-4 differs from isoform-1 by a 68 aa insertion (isoform-3) or a 20 aa insertion (isoform-4) in the second cytoplasmatic loop.
Most microarray approaches to study, for example GPR83 expression do not distinguish between different GPR83 isoforms as probe sets bind in the last exon, mainly the 3 0 UTR. To analyze, which GPR83 isoform is predominantly expressed by CD4 þ CD25
þ Tregs, we have designed specific primers to amplify the region of GPR83, which differs within the different isoforms.
À naive T cells isolated from BALB/c splenocytes, was used for GPR83 isoform expression analysis. As shown in Figure 1 , GPR83 isoform-2 is broadly expressed by all immune cells analyzed, whereas we could not detect GPR83 isoform-3 expression in any immune cell subset analyzed. Interestingly, GPR83 isoform-4 and iso- (Figure 1 ), we asked whether the additional 60 bp of isoform-4 might contribute to the induction of Tregs in an inflammatory environment in vivo.
For this purpose we constructed MSCV-based retroviral vectors encoding GPR83 isoform-1 (Iso-1), GPR83 isoform-4 (Iso-4) and eGFP under control of an internal ribosomal entry side. In addition, an empty control vector was generated that contained only eGFP (eGFP) (Figure 2a ). To address whether GPR83 isoform-1 transduced T cells have acquired the same immunosuppressive activity as GPR83 isoform-4 transduced T cells Figure 1 Differential expression of GPR83 isoform-1 and GPR83 isoform-4 in lymphocyte subsets and dendritic cells. Total RNA was isolated from sorted CD4
þ splenocytes of BALB/c and reverse transcribed by Superscript II (Invitrogen, Karlsruhe, Germany). PCR was performed using specific primer (5 0 -AAC ACG CCC TTC ACT TTG GTC-3 0 and 5 0 -ATG GAG ATC CGA GGC TTC A-3 0 ) allowing the discrimination between GPR83 isoform-1 (product 178 bp), GPR83 isoform-2 (product 53 bp), GPR83 isoform-3 (product 383 bp) and GPR83 isoform-4 (product 238 bp). RPS9 expression served as housekeeping control. Amplified products were analyzed by gel electrophoresis.
Figure 2 Overexpression of GPR83 isoform-4 in naive CD4
þ CD25 À T cells confers a regulatory phenotype in vivo. (a) Schematic drawing of the MCSV-based retroviral vectors encoding GPR83 isofom-1 (Iso-1) and GPR83 isoform-4 (Iso-4) under control of an internal ribosomal entry side (IRES) and the empty control vector (eGFP). cDNA encoding murine GPR83 isoform-4 or GPR83 isoform-1 was amplified by RT-PCR either from mouse CD4 þ CD25 þ sorted splenocytes or whole spleen, respectively, using specific primers (GPR83: 5 0 -GGA GCT CAG CCC TTG TGC-3 0 , 5 0 -TTG TGC CTG TTC TTT TCT GAG C-3 0 ). Retroviral vector construction and infections of MACS-sorted CD4 þ CD25
À splenocytes were performed as described earlier. 16 Colitis score was determined from histological analysis from colon section. Colons were removed 6-8 weeks after reconstitution and fixed in buffered formalin, embedded in paraffin, sectioned at 4 mm thicknesses and stained with H&E. The sections were evaluated in a blinded manner by a board-certified pathologist (ADG). Data shown represent mean scores from at least 15 animals from independent experiments. The Student's t-test was used to assess the significance of differences.
Regulatory T cell induction by GPR83 isoform-4
W Hansen et al in vivo, we examined the capacity of both GPR83 transduced T-cell subsets to inhibit the effector phase of a contact hypersensitivity (CHS) reaction leading to severe skin inflammation. As shown in Figure 2b , mice treated with mock-infected naive CD4 þ CD25 À T cells or control virus-infected T cells (eGFP) showed a normal CHS response upon challenge, whereas mice that were adoptively transferred with GPR83 isoform-4 transduced T cells developed a significantly reduced CHS response. Notably, GPR83 isoform-1 transduced T cells were not able to reduce the CHS response.
To
þ CD45RB hi T cells alone. In contrast, mice that were adoptively co-transferred with GPR83 isoform-4 transduced T cells exhibited an increase in body weight of about 25% with regard to the initial weight ( Figure 3c ) and showed significantly lower signs of disease (Figure 3d) . These results suggest that the additional 20 aa within the second cytoplasmatic loop of GPR83 isoform-4 are involved in the GPR83-dependent induction of Tregs in vivo.
Most recently, two studies on GPR83-deficient mice concluded that GPR83 is dispensable for the function of Tregs and not required for the maintenance of intestinal homeostasis. 8, 10 GPR83-deficient T cells exhibited similar functional properties in a T-cell transfer-mediated colitis model 10 and Foxp3 upregulation in naive T cells facilitated by homeostatic proliferation or tumor growth in vivo. 8 These observations seem to be in conflict with our conclusion that GPR83 isoform-4 is involved in the peripheral induction of Tregs in the course of an ongoing immune response. Nevertheless, as the peripheral induction of Tregs is an important checkpoint in the control of immune homeostasis it is conceivable 
Differential gene expression in re-isolated GPR83 isoform-4 transduced T cells
To gain first insights into the molecular mechanism involved in GPR83 isoform-4-mediated induction of Tregs in vivo, we re-isolated CD4 þ CD90.1 þ GPR83 isoform-1, GPR83 isoform-4 and control virus transduced T cells from the mesenteric lymph nodes (LNs) of CD90.2 þ Rag-deficient mice adoptively co-transferred with CD4
þ CD45RB hi and analyzed the gene expression profile using Affymetrix microarrays (Santa Clara, CA, USA). By this approach we have identified a variety of molecules known to be associated with Tregs including genes involved in, for example signaling and apoptosis (Figure 3a) . It is important to note that these genes were not regulated in GPR83 isoform-4 transduced T cells just on transduction, but only after re-isolation from the inflamed environment (data not shown). Among the Treg-associated genes we detected the transcriptional regulator Foxp3, the negative regulators PD-1 and CTLA-4 as well as the surface proteins CD25 and CD103 to be upregulated in re-isolated GPR83 isoform-4 transduced T cells. In addition, molecules with cytotoxic activity namely granzyme A (Gzma), granzyme B (Gzmb) and perforin were differentially expressed in T cells infected with GPR83 isoform-4 encoding retroviral vectors; as well as genes belonging to signaling pathways, which might be involved in the induction of Foxp3 expression (Figure 3a) .
The differential expression of Foxp3 and CD103 was confirmed on protein level by flow cytometry. For this purpose, sorted CD4 þ CD90.1 þ control vector (eGFP), GPR83 isoform-4 (Iso-4) and GPR83 isoform-1 (Iso-1) transduced T cells were adoptively transferred to dinitroflourobenzene (DNFB) sensitized CD90.2 þ BALB/c mice 24 h before DNFB challenge. Two days post challenge, mice were killed and transduced T cells were re-isolated based on CD4 þ CD90.1 þ expression and analyzed for CD103 and Foxp3 expression by FACS. As shown in Figure 3b , about 10% of re-isolated GPR83 isoform-4 transduced T cells expressed Foxp3, whereas 2% of control vector infected and 5% of GPR83 isoform-1 transduced CD4 þ CD90.1 þ T cells exhibited intracellular Foxp3 expression. In addition, 24% of re-isolated GPR83 isoform-4 transduced T cells expressed CD103 on their surface in contrast to GPR83 isoform-1 (16%) and control vector-infected (12%) T cells. Similar results were obtained from GPR83 isoform-4 and isoform-1 transduced T cells re-isolated from the mesenteric LN of Rag2-deficent mice adoptively co-transferred with CD4 þ
CD45RB
hi T cells (data not shown). Several pathways participating in the induction of Foxp3 have been proposed, suggesting that the expression of Foxp3 in the periphery is tightly regulated by multiple factors. The transcription factor NFAT has been shown to be involved in the regulation of Foxp3 expression by binding to an enhancer element within the promoter sequence. 11, 12 Interestingly, re-isolated GPR83 isoform-4 transduced T cells, which acquired a regulatory phenotype in vivo, upregulated NFAT and MAPK14 (p38) mRNA expression suggesting that conversion to Treg phenotype somehow involves such signaling pathways. Most recently, Toms et al. 10 proposed that GPR83 is a TGF-b responsive gene suggesting that TGF-b might be involved in the GPR83-dependent induction of Foxp3, probably through p38 MAP kinase as claimed by Huber et al. 13 To get a first hint which signaling pathways might be influenced by GPR83 isoform-4 in contrast to the shorter GPR83 isoform-1, we analyzed the phosphorylation status of Zap-70 and Erk1/2 in retrovirally transduced CD4 þ CD90.1 þ T cells re-isolated from the draining LNs or spleen of either Rag2-deficient mice adoptively co-transferred with CD4 þ CD45RB hi T cells or from mice sensitized and challenged with DNFB. As shown in Figure 3c , reisolated GPR83 isoform-4 transduced T cells exhibit a higher Zap-70 phosphorylation status than GPR83 isoform-1 or control vector transduced T cells in the draining LNs, but not the spleen. In contrast, we did not observe differences in the amount of Erk1/2 phophorylation between control vector, GPR83 isoform-4 or GPR83 isoform-1 transduced T cells re-isolated from the LN (Figure 3d) . However, the Erk1/2 phosphorylation status in LN cells is higher than in the spleen. These results suggest that the 20 aa present in the second cytoplasmatic loop of GPR83 isoform-4 somehow influence the phosphorylation status of Zap-70 in the course of an ongoing immune response. Interestingly, extensive database searches revealed a possible phosphorylation site at position (S181) within this particular side of the GPR83 isoform-4 (KinasePhos, Institute of Bioinformatics, National Chiao Tung University, Taiwan; NetPhos2.0, Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark). This sequence motif (QESQSLHDT; bold S indicates predicted phosphorylated serine residue) is also highly conserved within TNF receptor superfamily 16 (DSQSLHD) and in the ATPase class VI, type 11a (EEQSLHDVLF) and also predicted as possible phosphorylation side. Results from our microarray analysis presented here together with the slightly enhanced Zap-70 phosphorylation might provide helpful information for future follow-up experiments.
With regard to the inhibitory mechanisms used by Tregs to suppress other immune cells a broad variety of different molecules and mechanisms has been described. One potential mechanism for Treg-mediated suppression of T cells would be cytolysis of target cells. Several studies reported on the expression of granzymes by Tregs.
14, 15 Gondek et al. 14 have shown that granzyme Bdeficient Tregs were less efficient in suppression as wildtype Tregs. Well in line with these reports, gene expression analysis of re-isolated GPR83 isoform-4 transduced T cells exhibited an about sixfold upregulation in granzyme A and B mRNA expression.
Concluding remarks
In summary, we could demonstrate that GPR83 isoform-4, which is highly expressed by Tregs, is involved in the peripheral induction of Tregs in the course of a CHS response as well as T cell transfer-mediated wasting disease in contrast to GPR83 isoform-1. Both GPR83 isoforms just differ in a 20 aa cytoplasmatic loop that seems to be involved in signaling pathways leading to the induction of Foxp3. The identification of the so far unknown ligand would be helpful to better understand the role of the 20 aa tail present in GPR83-isoform-4 and might offer a therapeutic tool for the desirable induction of Tregs during autoimmunity and other unwanted inflammatory immune responses.
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